Bioxytran (BIXT) EBITDA Margin Growth (1y) (2011 - 2018)
Bioxytran (BIXT) EBITDA Margin Growth (1y) (2011 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | -1,651.00 |
| 10 | Bioxytran | 2.52 Mn | 2.27 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 65,346.00 |
| Mar 31, 2018 | 83,730.00 |
| Dec 31, 2017 | -50,424.00 |
| Sep 30, 2017 | 25,505.00 |
| Jun 30, 2017 | -39,708.00 |
| Mar 31, 2017 | 59,491.00 |
| Dec 31, 2016 | 23,034.00 |
| Sep 30, 2016 | -18,424.00 |
| Jun 30, 2016 | 296,459.00 |
| Mar 31, 2016 | -137,770.00 |
| Dec 31, 2015 | -145,113.00 |
| Sep 30, 2015 | 265,981.00 |
| Jun 30, 2015 | -307,393.00 |
| Mar 31, 2015 | -9,110.00 |
| Dec 31, 2014 | 151,914.00 |
| Sep 30, 2014 | -219,138.00 |
| Jun 30, 2014 | 49,025.00 |
| Mar 31, 2014 | 88,281.00 |
| Dec 31, 2013 | 105,559.00 |
| Sep 30, 2013 | 440,530.00 |